Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jean-Yves Douillard MD, PhD
Jean-Yves Douillard MD, PhD Advisory Board
Jeffrey Kirshner MD, FACP, FASCO
Jeffrey J. Kirshner MD, FACP, FASCO Advisory Board
Roxana Dronca MD
Roxana S. Dronca MD Advisory Board
See All Experts
story of the week
Published in Oncology

Journal Scan / Research · May 12, 2016

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Pancreatic Cancer

JAMA: The Journal of the American Medical Association

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Axel Grothey MD

JAMA: The Journal of the American Medical Association
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial
JAMA 2016 May 03;315(17)1844-1853, P Hammel, F Huguet, JL van Laethem, D Goldstein, B Glimelius, P Artru, I Borbath, O Bouché, J Shannon, T André, L Mineur, B Chibaudel, F Bonnetain, C Louvet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated